Innoviva, Inc. (INVA)
19.60
+0.05
(+0.26%)
USD |
NASDAQ |
Jan 21, 16:00
19.75
+0.15
(+0.77%)
After-Hours: 20:00
Innoviva Free Cash Flow: 196.54M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Eli Lilly & Co. | 6.436B |
| Merck & Co., Inc. | 13.05B |
| Axsome Therapeutics, Inc. | -101.39M |
| Keros Therapeutics, Inc. | 87.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 49.73M |
| Cash from Investing (Quarterly) | 18.41M |
| Cash from Financing (Quarterly) | 10.84M |
| Free Cash Flow Per Share (Quarterly) | 0.5721 |
| Free Cash Flow to Equity (Quarterly) | 306.97M |
| Free Cash Flow to Firm (Quarterly) | 52.30M |
| Free Cash Flow Yield | 12.68% |